A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy

BACKGROUND: Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This study explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Kate, Davidson, Ian, Rance, Mark, Buesch, Katharina, Acaster, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353428/
https://www.ncbi.nlm.nih.gov/pubmed/34374872
http://dx.doi.org/10.1186/s41687-021-00344-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353428/
https://www.ncbi.nlm.nih.gov/pubmed/34374872
http://dx.doi.org/10.1186/s41687-021-00344-8

Ejemplares similares